Could a common arthritis drug slow hand joint damage?
NCT ID NCT07501507
First seen Apr 07, 2026 · Last updated May 19, 2026 · Updated 5 times
Summary
This study tests whether methotrexate, a drug used for other types of arthritis, can slow joint damage in people with severe hand osteoarthritis that hasn't responded to standard treatments. About 170 adults with erosive hand osteoarthritis will receive either methotrexate or a placebo for one year. The main goal is to see if the drug reduces worsening of joint damage on X-rays.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for EROSIVE HAND OSTEOARTHRITIS are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
CHU de Nice
Nice, 06000, France
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.